Korean J Urol.  1989 Oct;30(5):672-677.

The Clinicopathological Study on Prostatic Carcinoma: The Evaluation of Prognosis by Gleason's Method

Affiliations
  • 1Department of Urology, College of Medicine, Pusan National University, Pusan, Korea.
  • 2Department of Urology, Catholic Medical College, Seoul, Korea.
  • 3Department of Urology, College of Medicine, Chonnam National University, Kwangju, Korea.
  • 4Department of Urology, College of Medicine, Chonbuk National University, Junju, Korea.
  • 5Department of Urology, Inje Medical College, Pusan, Korea.
  • 6Department of Urology, Merynoll Hospital, Pusan, Korea.

Abstract

A clinicopathological study based on stages, Gleason's method and srvival rates was carried out in 149 cases of prostatic carcinoma treated at Pusan National University Hospital and five participating hospitals. 1. The distribution of each stage was:17 (11.4%) in stage A, 37 (24.8%) in stage B, 22 (14.8%) in stage C, and 73 cases (49.0%) in stage D. Of Gleason's score between primary and secondary pattern, the uniform cases were in 32%, the cases of 1 step differences were in 59 %, the cases of 2 step differences were in 9%, and none in more than 2 step differences. 2. The score sum of Gleason's method was inclined to be higher as the stage became higher. 3. The survival rates were declining as stages excluding cases between stage A and B became higher. As the Gleason's score (primary and secondary pattern, Gleason's sum, Gleason's category) became higher, the survival rates tended to decline. 4. Comparing the death rates of our cases to that of VACURG study of USA and that of Harada of Japan according to Gleason's score, there were no statistical differences (a>0.05). The prognosis of prostatic carcinoma depends on the histological factor, which in dictates the significance of Gleason's method. Also the authors believe that a common ground of basis such as Gleason's method is useful in comparative studies.

Keyword

prostatic carcinoma; Gleason's score

MeSH Terms

Busan
Japan
Mortality
Prognosis*
Survival Rate
Full Text Links
  • KJU
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr